Skip to main content

Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model

  • 2021-07-26
  • PLOS ONE 16(7)
    • S. Shen
    • Wei‐Jen Chen
    • Hui-Fang Chu
    • Shiuan-Huei Wu
    • Yu-Ru Wang
    • Tang-Long Shen

Abstract

Intestinal mucositis is a commonly encountered toxic side effect in patients undergoing 5-fluorouracil (5-FU)-based chemotherapy. Numerous studies have shown that probiotics enable improving chemotherapy-induced intestinal mucositis, but the beneficial effects of probiotics differ depending on the strain. Therefore, in the present studies we suggest that S. thermophilus ST4 separated from raw milk may assess mucoprotective activity in 5-FU-induced intestinal mucositis. In our causal-comparative study design, fifteen mice were randomized assigned into three groups (n = 5/each group): control group, 5-FU group and 5-FU+S. thermophilus ST4 group. The control group was orally administrated saline only, and the 5-FU group was followed by intraperitoneal injection of 5-FU for 3 days after 10-day saline administration, and the 5-FU+S. thermophilus ST4 group was intragastrically subjected for S. thermophilus ST4 once per day during the whole experiment, starting from the first day of the experiment, followed by 5-FU intraperitoneal injection for 3 days after 10-day S. thermophilus ST4 pretreatment. Diarrhea score, pro-inflammatory cytokines serum levels, intestinal histopathology and short chain fatty acid were assessed. Here, we demonstrated the beneficial effects of S. thermophilus ST4 derived from raw milk against 5-FU-induced intestinal mucositis, including body weight reduction, appetite loss and diarrhea. Intrinsically, S. thermophilus ST4 effectively maintained epithelium structure in small intestines and colons as well as reduced the intestinal inflammation. Besides, S. thermophilus ST4 significantly increased the expression of acetic acid, reinforcing the muco-protective effects. In conclusion, our results demonstrate that S. thermophilus ST4 supplementation ameliorates 5-FU-induced intestinal mucositis. This suggests probiotic may serve as an alternative therapeutic strategy for the prevention or management of 5-FU-induced mucositis in the future.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Streptococcus thermophilus SP4Improved AppetiteBeneficial
Moderate
Streptococcus thermophilus SP4Increased Acetic Acid Levels in FecesBeneficial
Moderate
Streptococcus thermophilus SP4Maintained Intestinal Epithelial HomeostasisBeneficial
Large
Streptococcus thermophilus SP4Reduced Body WeightBeneficial
Moderate
Streptococcus thermophilus SP4Reduced Diarrhea IncidenceBeneficial
Moderate
Streptococcus thermophilus SP4Reduced Intestinal InflammationBeneficial
Large
Streptococcus thermophilus TH-4Increased Acetic Acid Levels in FecesBeneficial
Moderate
Streptococcus thermophilus TH-4Maintained Epithelium StructureBeneficial
Large
Streptococcus thermophilus TH-4Reduced Appetite Loss IncidenceBeneficial
Moderate
Streptococcus thermophilus TH-4Reduced Body WeightBeneficial
Moderate
Streptococcus thermophilus TH-4Reduced Diarrhea RateBeneficial
Moderate
Streptococcus thermophilus TH-4Reduced Intestinal InflammationBeneficial
Large

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.